Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...
Lawyer Monthly

Moderna to Pay Up to $2.25B to Settle COVID-19 Vaccine Patent Lawsuit

Moderna will pay up to $2.25B to settle a patent lawsuit over lipid nanoparticle technology used in its COVID-19 vaccine.
Yahoo

Bayer sues COVID vaccine makers over mRNA technology

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A box of Moderna Spikevax (COVID-19 Vaccine, mRNA) is kept in the refrigerator at Skippack Pharmacy in Schwenksville, ...
Hosted on MSN

COVID vaccine for cancer? mRNA technology shows unexpected promise

In a groundbreaking development, a new study has unveiled that the mRNA COVID-19 vaccines, originally designed to combat the coronavirus, may also play a pivotal role in enhancing cancer treatment ...

Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang

By Puyaan Singh March 4 (Reuters) - Moderna shares rose 9% on Wednesday after it settled a long-running legal battle over the ...
GeekWire

First multi-coronavirus vaccine enters human testing, built on UW Medicine technology

A model of a new vaccine targeting a family of coronaviruses that includes the virus that causes COVID-19. The image highlights pieces of several different viruses attached to a computer-designed ...
Yahoo

New COVID vaccine says it's for the ‘senior class' - does it reduce side effects?

Add Yahoo as a preferred source to see more of our stories on Google. A nurse draws up doses of the Moderna COVID-19 for a vaccination clinic in St. Helena in 2021. Moderna is offering a new, low-dose ...